Understanding self-harm behavior in at-risk adolescents
Influences on and Prevention of Self-harm Behaviour Among the Most At-risk Adolescents
This study is trying to understand the risks of self-harm in at-risk teens who have been hospitalized for suicide risk, to help create better treatment guidelines.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 400 (estimated) |
| Ages | 13 Years to 18 Years |
| Sex | All |
| Sponsor | University of Ljubljana, Faculty of Medicine Academic / other |
| Locations | 2 sites (Ljubljana and 1 other locations) |
| Trial ID | NCT05765864 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify acute and long-term risks associated with self-harm behaviors in adolescents, particularly those hospitalized for suicide risk. It will involve approximately 200 at-risk adolescents and an equal number of healthy controls, assessing various demographic, clinical, and psychological factors through questionnaires and genetic analyses. The study will track self-harm incidents and evaluate changes in risk factors over time, ultimately developing guidelines for more effective treatment of these behaviors.
Who should consider this trial
Good fit: Ideal candidates include adolescents aged 13-19 who exhibit self-harming behaviors without suicidal intent.
Not a fit: Patients with confirmed acute psychotic disorders, severe physical illnesses, or those who have a history of suicidality or self-injurious behavior in a first-degree relative may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved identification and treatment strategies for adolescents at risk of self-harm.
How similar studies have performed: Other studies have shown success in identifying risk factors for self-harm in adolescents, but this specific approach is novel in its comprehensive methodology.
Eligibility criteria
Show full inclusion / exclusion criteria
CLINICAL GROUP: Inclusion Criteria: * Suicidality * Self-harming with no intention to die Exclusion Criteria: * Confirmed acute psychotic disorder * Intellectual disability * Severe physical illness (e.g. cardiovascular or renal disease) * Disease of the central nervous system (e.g. encephalitis, brain injury or haemorrhage, epilepsy) * Acute poisoning (including with psychoactive substances) CONTROL GROUP: Inclusion Criteria: \- Age 13-19 Exclusion criteria: * Suicidality * Self-harming with no intention to die * Known mental disorder (e.g. depression, bipolar disorder, schizophrenia, intellectual disability) * Severe physical illness (e.g. cardiovascular or renal disease) * Disease of the central nervous system (e.g. encephalitis, brain injury or haemorrhage, epilepsy) * Acute poisoning (including with psychoactive substances) * Mental disorder, history of suicidality or self-injurious behaviour in a first-degree relative (a parent or a sibling).
Where this trial is running
Ljubljana and 1 other locations
- Medical Faculty - University of Ljubljana — Ljubljana, Slovenia (Active_not_recruiting)
- University Psychiatric Clinic Ljubljana — Ljubljana, Slovenia (Recruiting)
Study contacts
- Principal investigator: Maja Drobnič Radobuljac — University Psychiatric Clinic Ljubljana
- Study coordinator: Maja Drobnič Radobuljac
- Email: maja.radobuljac@psih-klinika.si
- Phone: 015874840
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.